PD-1 Protects against Inflammation and Myocyte Damage in T Cell-Mediated Myocarditis

Tarrio, Margarite L, Grabie, Nir, Bu, De-xiu, Sharpe, Arlene H, Lichtman, Andrew H·2012·The Journal of Immunology

DOI 10.4049/jimmunol.1200389

Cited by (287)

Items 201–287 of 287

Two Sides to Every Proinflammatory Coin
Gabriel Kenneth Griffin, Andrew H. Lichtman · 2013 · Circulation
Immune Checkpoints Are New Therapeutic Targets in Regulating Cardio-, and Cerebro-Vascular Diseases and CD4+Foxp3+ Regulatory T Cell Immunosuppression
Ying Shao, William Y. Yang, Gayani Nanayakkara, Fatma Saaoud, Mohammed Ben Issa, Keman Xu, Yifan Lu, Xiaohua Jiang, Sadia Mohsin, Hong Wang et al. · 2024 · International Journal of Drug Discovery and Pharmacology
Immune checkpoint inhibitor-associated myocarditis: a review of current state of knowledge
Keila C Ostos-Mendoza, Valeria Saraiba-Rabanales, Paola Gutierrez‐Gallegos, Emily Wang, Efstratios Koutroumpakis, Salil Kumar, Shaden Z. Khalaf, Hyeon-Ju Ali, Anita M Deswal, Nicolas L. Palaskas · 2025 · The Journal of Cardiovascular Aging
Evaluating the effect of PD-1 inhibitors on left ventricular function in lung cancer with noninvasive myocardial work
Xia Li, Chujun Wang, Ruirui Kang, Yu Zhao, Lili Chen, Fengzhen Liu, Xiaolin Wang, Yulan Peng, Chunquan Zhang · 2023 · Quantitative Imaging in Medicine and Surgery
Multiorgan failure caused by pembrolizumab and axitinib in a woman affected by metastatic clear cell renal cell carcinoma: A case report and literature review
Andrea Di Marco, Grazia Artioli, Adolfo Gino Favaretto, Nicolò Cavasin, Umberto Basso · 2024 · Medicine
PD-1/PDL1 Blockade Exacerbates Pancreatic Damage and Immune Response in a Mouse Model of Acute Pancreatitis
Ting Xie, Ningzhi Wang, Guanghuai Yao, Songxin Xu, Dan Wang, Xinnong Liu, Liang‐Hao Hu, Guotao Lu, Ruihua Shi, Yanbing Ding · 2021 · Inflammation
PD-1 inhibitor therapy causes multisystem immune adverse reactions: a case report and literature review
Na Yin, Xiangliang Liu, Xiaojun Ye, Wei Song, Jin Lu, Xiao Chen · 2022 · Frontiers in Oncology
Tolerated Re-Challenge of Immunotherapy in a Patient with ICI Associated Myocarditis: A Case Report and Literature Review
Walid Shalata, Zoé Gabrielle Attal, Rajeh Shhadi, Amjad Abu Salman, Ashraf Abu Jama, Sondos Shalata, Kais Halumi, Alexander Yakobson · 2023 · Medicina
The Two Faces of Angiopoietin‐Like Protein 2 in Cancer
Haruki Horiguchi, Tsuyoshi Kadomatsu, Yuichi Oike · 2024 · Cancer Science
The real-world safety of Nivolumab: a pharmacovigilance analysis based on the FDA adverse event reporting system
Yutong Wu, Yue Zhou, Shiyue Xia, Zhaoyou Meng · 2025 · Frontiers in Immunology
Nivolumab‐induced fatal myocarditis: A case report
Kavya Bharathidasan, Mahmoud Hassan Abdelnabi, John Abdelmalek, Jasmine Sekhon, William Butler, Miguel Quirch, Erwin Argueta Sosa · 2023 · Clinical Case Reports
A case of carrelizumab-associated immune myocarditis
Lan-Zhen Zhao, Guang Liu, Quan-Fu Li, Gang Chen, Gao-Wa Jin · 2021 · Asian Journal of Surgery
Immune Checkpoint Inhibitor (ICI)-Related Cardiotoxicity
Abdulrazzak Zarifa, Juan Lopez‐Mattei, Nicolas L. Palaskas, Cezar Iliescu, Jean‐Bernard Durand, Peter Y. Kim · 2021 · Advances in experimental medicine and biology
Early detection and management of immune-related myocarditis: Experience from a case with advanced squamous cell lung carcinoma
Li Tu, Jiewei Liu, Zhixi Li, Yanyang Liu, Feng Luo · 2020 · European Journal of Cancer
Immunotherapy of solid tumors: how safely treat the patients
Joanna J. Domagala-Kulawik, Przemysław Leszek, Witold D. Owczarek, Tomasz Rawa, Maria Stelmachowska‐Banaś, Piotr Lukasz Rutkowski · 2020 · Polskie Archiwum Medycyny Wewnętrznej
Metabolic consequences of immune checkpoint inhibitors: A new challenge in clinical practice
Ioannis Parthymos, George L. Liamis, Evangelia C. Dounousi, George E. Pentheroudakis, Davide Mauri, George Zarkavelis, Matilda Florentin · 2020 · Critical Reviews in Oncology/Hematology
Myocarditis and pericarditis following mRNA COVID-19 vaccination in younger patients: is there a shared thread?
Raffaella Mormile · 2022 · Expert Review of Cardiovascular Therapy
Exosomal miRNAs as biomarkers in predicting chemotherapy‑induced cardiotoxicity in patients with cancer (Review)
Vedant Shah, Viraj S. Panchal, Abhi Shah, Bhavya Vyas, Subham Bhowmik, Ishita Panchal, Pragya Jain · 2025 · Medicine International
Myocardial Expression of PD-L1 as a Marker of Poor Prognosis in Immune Checkpoint Inhibitor–Associated Myocarditis
Takuro Imaoka, Shingo Sakashita, Satoshi Matsuoka, Kimi Sato, Yoichi Naito, Genki Okumura, Shohei Koyama, Koji Hozawa, Yuka Nakamura, Yuma Shibutani et al. · 2026 · JACC CardioOncology
The incidence and relative risk of major adverse cardiovascular events and hypertension in patients treated with immune checkpoint inhibitors plus tyrosine-kinase inhibitors for solid tumors: a systemic review and meta-analysis
Chiara Ciccarese, Annunziato Anghelone, Alessio Stefani, Antonio Cigliola, Alessandro Strusi, Filippo D’Agostino, Emilio Bria, Roberto Iacovelli, Giampaolo Tortora · 2024 · Expert Review of Anticancer Therapy
Unmasking the Rare but Lethal Cardiac Complications of Immune Checkpoint Inhibitor Therapy: A Review of Mechanisms, Risk Factors, and Management Strategies
Laudy Chehade, Noura Abbas, Kristel Dagher, Mohamad Mourad, Ghid Amhez, Mohamad Bahij Moumneh, Lara Kreidieh, Firas Kreidieh, Maria Mariete Aragão Melo Pereira, Ali I. Shamseddine · 2025 · Current Treatment Options in Oncology
A case of acute myocarditis induced by PD-1 inhibitor (sintilimab) in the treatment of large cell neuroendocrine carcinoma
Siming Zheng, Haiyu Zhang, Bingshuang Hu, Jiaxiong Zhou, Lei Wen, Min-Ying Li · 2023 · Heliyon
Challenges and solutions in management of cardiotoxicity induced by checkpoint inhibitors
Beáta Mladosievičová, Zuzana Országhová, Magdaléna Jablonická, Mária Rečková, Michal Chovanec, Michal Mego · 2020 · Klinicka onkologie
Immune-checkpoint inhibitor toxicity during a pandemic: Overcoming patient fears to provide care. A case report
Christopher T. Elder, Elizabeth C Davis, Stephanie Jaipal, Charles E Wight · 2021 · Journal of Oncology Pharmacy Practice
What the Cardiologist Needs to Know About Cancer Immunotherapies and Complications
Marina Frayberg, Anthony Yung, Leyre Zubiri, Daniel A. Zlotoff, Kerry Lynn Reynolds · 2021 · Current Treatment Options in Oncology
Sudden and severe cardiotoxicity induced with pembrolizumab, its clinical course, therapeutic intervention, and outcome
Tomohiro Matsumoto, Koji Fukuda, Taichi Yoshida, Kazuhiro Shimazu, Daiki Taguchi, Hanae Shinozaki, Katsuhito Seki, Takayuki Yamanaka, Mako Ootaka, Hiroshi Nanjyo et al. · 2021 · International Cancer Conference Journal
Diretrizes brasileiras de manejo de toxicidades imunomediadas associadas ao uso de bloqueadores de correceptores imunes
Grupo de Trabalho da Sociedade Brasileira de Oncologia Clínica · 2017 · Brazilian Journal of Oncology
A two-stage ensemble learning based prediction and grading model for PD-1/PD-L1 inhibitor-related cardiac adverse events: A multicenter retrospective study
Xitong Cheng, Zhaochun Wu, Jierong Lin, Bitao Wang, Shunming Huang, Maobai Liu, Jing Yang · 2024 · Computer Methods and Programs in Biomedicine
Changes in tumor and cardiac metabolism upon immune checkpoint
Anna‐Sophia Leven, Natalie Wagner, Stephan Nienaber, Daniel Messiha, Alpaslan Tasdogan, Selma Ugurel · 2024 · Basic Research in Cardiology
Immunotherapy-associated Cardiotoxicity: a Comprehensive Review of Checkpoint inhibitors, monoclonal, cellular, and cytokine-based Treatments
Kalliopi Keramida, Theodora-Christina Kyriakou, Athos Antoniades, Carlo Gabriele Tocchetti · 2025 · Current Treatment Options in Oncology
Clinical characteristics, treatment and prognosis of pembrolizumab induced myocarditis
Zhaoquan Wu, Wei Sun, Chunjiang Wang · 2025 · Investigational New Drugs
Intracellular Cardiac Signaling Pathways Altered by Cancer Therapies
Shane S. Scott, Ashley N. Greenlee, Ethan J. Schwendeman, Somayya J. Mohammad, Michael T. Naughton, Anna Matzko, Mamadou Diallo, Matthew Stein, Rohith Revan, Taborah Z. Zaramo et al. · 2022 · Springer eBooks
Cardiovascular Disease Risk Factors, Immune Checkpoints and Tregs
Ying Shao, Fatma Saaoud, Keman Xu, Yifan Lu, Xiaohua Jiang, Hong Wang, Xiaofeng Yang · 2024 · Advances in biochemistry in health and disease
PD-1/PD-L1 Signaling in Non-ICI Myocarditis
Laura I.E. Yousif, Aukje G. Sijtema, Ymke Appels, Pieter F. van den Berg, Joseph Pierre Aboumsallem, Olivier Christiaan Manintveld, Dirk Jan Duncker, Rudolf A. de Boer, Wouter C. Meijers · 2026 · JACC Basic to Translational Science
Immune checkpoint inhibitor‐related myocarditis in thymic epithelial tumors: Recent progress and perspectives
Jianqiong Yin, Zhuoran Yao, Jing Pan, Lu Gan, Jianxin Xue · 2023 · MedComm – Oncology
Childhood cancer survivors: The integral role of the cardiologist and cardiovascular imaging
Wendy J. Bottinor, Jonathan H. Soslow, Justin A. Godown, Marcus F. Stoddard, Evan C. Osmundson, Carrie Geisberg Lenneman, Debra L. Friedman, Scott C. Borinstein · 2020 · American Heart Journal
Muscle expression of PD1 and PD-L1 may predict the severity and outcomes of neuromuscular immune-related adverse events caused by immune checkpoint inhibitor treatment
MengTing Yang, Fan Li, Zhaoyu Chen, Feng Gao, Wei Zhang, ZhaoXia Wang, Yun Yuan, Yawen Zhao · 2025 · Clinical Rheumatology
Electrocardiographic predictors of major adverse cardiovascular events in immune checkpoint inhibitor–associated myocarditis
Kanghao Zhou, Guangcheng Liu, Bin Zhang, Xiong Zhang, Wei Wu · 2026 · Cardio-Oncology
Mechanisms and biomarkers of immune checkpoint inhibitor-associated myocarditis: from T cell imbalance to multicellular crosstalk
Jiawang Huang, Xiuli Xu, Yucheng Jin, L J Qiao, Heng Yu, Wenbo Gao, Caie Li · 2026 · Frontiers in Immunology
A Review of Extraintestinal Manifestations & Medication-Induced Myocarditis and Pericarditis in Pediatric Inflammatory Bowel Disease
Kevin T Cesa, Catherine G Cunningham, Tyler Harris, Whitney M. Sunseri · 2022 · Cureus
Navigating Neurologic Adverse Events in Immune Checkpoint Inhibitor Therapy: Challenges and Strategies
Arzu Aldemir Atmaca · 2023 · Eurasian Journal of Medical Advances
Cardiovascular disease burden in patients with urological cancers: The new discipline of uro‐cardio‐oncology
Yi Zheng, Ying Liu, Ziliang Chen, Yunpeng Zhang, Zuo Qi, Ning Wu, Zhiqiang Zhao, Gary Tse, Yong Wang, Hailong Hu et al. · 2024 · Cancer Innovation
Mechanisms of myocardial toxicity of antitumor drugs and potential therapeutic strategies: A review of the literature
Jia Yang, Qihong Wu, Zhi‐gang Yang, Ranran Sun, Kun Zhang, Xia Nan Guo, Rong Xu, Yingkun Guo · 2024 · Current Problems in Cardiology
Cardiovascular effects of innovative therapies in lung cancer
Anne‐Claire Toffart, Hélène Pluchart, Nicolas Girard · 2020 · European Respiratory Society eBooks
Myocarditis Induced by Immunotherapy in Metastatic Melanoma—Review of Literature and Current Guidelines
Anna Malgorzata Czarnecka, Marcin Kleibert, Iga Płachta, Paweł Rogala, Michał Wągrodzki, Przemysław Leszek, Piotr Lukasz Rutkowski · 2022 · Journal of Clinical Medicine
Fulminant Myocarditis Complicated with Immune Checkpoint Inhibitor in Patients with Thymoma: Report of Three Cases
Daozheng Huang, Feier Song, Weidai Zhang, Huan Ma, Xingtao Lin, Tiehe Qin, Shouhong Wang · 2023 · International Journal of Cardiovascular Practice
CXCR5+TIM-3-PD-1+ stem-like cytotoxic CD8+ T cells: elevated in chronic rhinosinusitis and associated with disease severity
Zhichen Liu, Zixuan Zhao, Huanxia Xie, Ning Lu, Jisheng Liu, Qingqing Jiao · 2024 · Frontiers in Immunology
Cancer Therapy–Related Cardiac Dysfunction in Patients Using Immune Checkpoint Inhibitors
Chieh-Yu Chang, Chun‐Chi Chen, Wen‐Kuan Huang, Ming‐Jer Hsieh, Ming‐Lung Tsai, Cheng-Hung Lee, Tien‐Hsing Chen, Shao‐Wei Chen, Kuo‐Chun Hung, Wen‐Cheng Chang et al. · 2025 · JACC Asia
Blood-derived ratio indexes associated with severity and prognosis of immune checkpoint inhibitor-related cardiotoxicity: a retrospective analysis
Lingfei Guo, Zhenli Li, Guangbin Gao, Jing Liu, Zhengkun Guan, Tiezhu Yao, Guang Liu, Qian Jiao, Tenghui Wang, Yansong Wang et al. · 2025 · Frontiers in Oncology
Crocins Ameliorate Experimental Immune Checkpoint Inhibitor-Related Myocarditis by Targeting the Hpx/Nrf2/HO-1 Pathway
Jing Yan, Qingqing Cai, Li Yl, Zhang Ye, Ye Zhao, Fangbo Zhang, Huamin Zhang · 2026 · International Journal of Molecular Sciences
Nicotinamide prevents anti-PD1 immune checkpoint inhibitor-associated early stages of cardiotoxicity
Lu Bai, Jing Zhao, Kang Dong, Maomao Zhao, Yanhang Zhao, Qianyue Cong, Yongxiang Wang, Xiaowei Niu, Jianming Tang, Ming Bai · 2026 · Science China Life Sciences
Immune Checkpoint Inhibitor–Associated Cardiovascular Toxicity: Mechanisms, Clinical Manifestations, and Clinical Impact
Zhengyu Chen, Meijie Zheng, Yuxuan Li, Xiwu Zhang, Jinjin Dou · 2026 · Cardiovascular Toxicology
Deficit in blood MAIT cells, altered cytokines and T cell dynamics in patients with coronary artery disease
Dimitrios Stavridis, Max Wacker, Rauf Safarov, Nicola Testa, George Awad, Sam Varghese, Katrin Borucki, Jens Wippermann, Priya Veluswamy · 2026 · Cellular Immunology
Longitudinal Evaluation of Immune Checkpoint Inhibitor‐Induced Fatigue Syndrome by Rest, Stress, and Speckle‐Tracking Strain Echocardiography
Katy K. Tsai, Andrew Young Chang, Christiane M. Abouzeid, Mandar A. Aras, Qizhi Fang, Dwight Bibby, Leila Haghighat, Joan F. Hilton, ADIL I. DAUD, Nelson B. Schiller · 2025 · Echocardiography
Krebserkrankungen heilen und das Herz schützen
Christopher Hohmann, Stephan Ernst Baldus, Roman Pfister · 2019 · Herz
A Case of Anorectal Malignant Melanoma with Lymph Node Recurrence Showing a Complete Response to Nivolumab Treatment
Mikio Kawamura, Eiki Ojima, Shinji Yamashita, Kiyoshi Hashimoto, Hideki Watanabe, Kazuo Fukutome, Yasuhiko Mohri · 2021 · 日本消化器外科学会雑誌
Potential Novel Therapeutic Target to Improve Graft Survival: New Insights Into the Role of Checkpoint Molecules in Heart Transplant Rejection
Bettina Heidecker · 2021 · Circulation Heart Failure
Checkpoint Inhibitor-Associated Autoimmunity: What a Rheumatologist Needs to Know.
Nilasha Ghosh, Anne R. Bass · 2022 · PubMed
Immunological properties of parthenogenetic stem cell derived cardiomyocytes and their application in cardiac tissue engineering
Satish Galla · 2016 · eDiss (Georg-August-Universität Göttingen)
Overview of the Cardiotoxicity Induced by PD-1/PD-L1 Immune Checkpoint Inhibitor in Critical Care
Ruiting Li, Xiaojing Zou, Huaqing Shu, You Shang · 2021 · Intensive Care Research
Repercussão cardiovascular das terapias anticâncer / Cardiovascular outcomes of anticancer therapies
Júlia Oliveira Silva, Marcelo de Araújo Lopes Júnior, INGRIDY MARIA OLIVEIRA FERREIRA, Beatriz Vieira Nascimento Silva · 2021 · Brazilian Journal of Health Review
Acute and Chronic Hepatitis B Virus Infection, Immune Response
Mala K. Maini, Abhishek Das, Anna Schurich · 2014 · Springer eBooks
Association between Histological Changes and Clinical Manifestations of Fulminant Myocarditis
Chen Chen, Dao Wen Wang · 2022 · Springer eBooks
Clinical Progress and Prospect of Traditional Chinese Medicine Combined with Immune Checkpoint Inhibitors in the Treatment of Non-Small Cell Lung Cancer
文韬郭 · 2022 · Advances in Clinical Medicine
Data from Clinical Significance of Pancreatic Atrophy Induced by Immune-Checkpoint Inhibitors: A Case–Control Study
Yael Eshet, Erez N. Baruch, Ronnie Shapira‐Frommer, Yael Steinberg‐Silman, Teodor Kuznetsov, Guy Ben‐Betzalel, Sameh Daher, Iris Gluck, Nethanel Asher, Sara Apter et al. · 2023
Valoración del miocardio mediante resonancia magnética cardiaca en pacientes en tratamiento activo con inhibidores de puntos de control inmunitario
Beatriz Barrios Collado · 2023
Regulation and diagnosis of cardiovascular diseases by microRNAs derived from immune cells
Rafael Blanco Domínguez · 2022
Association between PD-1/PD-L1 and Myocarditis: A Mendelian Randomization Study
亮嘉曾 · 2024 · Advances in Clinical Medicine
Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse model
Caroline Schoenherr, Stefan Pietzsch, Cristina Barca, Franziska E. Müller, Frauke S. Bahr, Martina Kasten, André Zeug, Sergej Erschow, Christine Susanne Falk, Evgeni G. Ponimaskin et al. · 2025 · Frontiers in Molecular Medicine
Adverse reactions of immune checkpoint inhibitors
Загидуллина Эмилия Рафилевна, Vitalii B. Kaliberdenko, Кулиева Эльвина Рустамовна, Victoria S. Beter, Tatiana V. Pronkina, Valeria A. Kushner, V. V. Taran · 2025 · Medical Immunology (Russia)
Immune Checkpoint Inhibitors and Myocarditis: Clinical Impact and Underlying Mechanisms
Ali Moradi, Nada Muhamed SAID, Sina Khoshniyat, Kurt Ramey, Stefan A Longobardi, Robert J. Subbiondo · 2025 · Advances in biochemistry in health and disease
Cardiac Dysfunction and Heart Failure Caused by Cancer Therapy-Induced Cardiotoxicity
Raluca Șoșdean, Silvia Giuchici, Loredana Nicoleta Ionică, Adina V. Furdui-Lința, Adrian Sturza, Danina Mirela Muntean, Daniel Lighezan, Roberto Bolli · 2025 · Advances in biochemistry in health and disease
Additional file 1 of Immune checkpoint inhibitors-related myocarditis in patients with cancer: an analysis of international spontaneous reporting systems
Ma, Rulan, Quanziang Wang, Meng, Deyu, Li, Kang, Zhang, Yong · 2021 · Figshare
Additional file 1 of Immune checkpoint inhibitor-related adverse cardiac events in patients with lung cancer: a systematic review and meta-analysis
Zhang, Xiao-Tong, Ge, Nan, Xiang, Zi-Jian, Liu, Tao · 2022 · Figshare
Heart Failure in Cancer Patients
Edwin Lu, Ajay Vallakati · 2026 · Elsevier eBooks
Thérapies du cancer de nouvelle génération et fonctions cognitives : Nouveaux concepts, nouveaux mécanismes, biomarqueurs originaux.
Nicola Coppola · 2023 · theses.fr (ABES)
Association between T cell exhaustion and the recurrence of atrial fibrillation after cryoballoon ablation
Rong Suo, Shiyu Qi, Wenhua Song, Bingshuo Shi, H F Zhang, Daiqi Liu, Tong Liu, X Liu · 2026 · Frontiers in Immunology
Immune checkpoint inhibitor-related cardiotoxicity: a cellular pharmacology perspective on susceptibility and resistance
Hui Fang, Bingjie Guo, Yajun Sun, Wujia Jin, Wenting Wang · 2026 · Frontiers in Pharmacology
Clinical application and research advances of positron emission tomography molecular imaging in immune checkpoint inhibitor-associated myocarditis
Yuhu Lv, Danzha Zheng, Zhangyongxue Zhou, Zhibo Dai, Siqi Wei, Xinyu Liu, Xiaoli Lan, Zairong Gao, Chunxia Qin · 2026 · Journal of Nuclear Cardiology
Knowledge landscape and hotspots of scientific publications on myocarditis: a bibliometric analysis from 2000 to 2024
Xifeng Zheng, Yan He, Weiqin Lin, Ching‐Hui Sia · 2026 · Singapore Medical Journal
Immune checkpoint inhibitor-induced cardiotoxicity: from immune mechanisms to clinical surveillance and targeted therapies
Nathan K. Chen, Kathryn D. Hok, Narsi Chokshi, Anthony Shadid, Haydn E. Rich, Lavanya Gunamalai, Marie–Françoise Doursout, Nirmal K. Banda, Pooja Shivshankar · 2026 · Frontiers in Cardiovascular Medicine
Cardiotoxicity of pembrolizumab therapy: narrative review
Jas Virk · 2026 · Exploration of Cardiology
The Role of the KLF Family in T-Cell-Mediated Regulation of Cardiovascular Diseases: Molecular Mechanisms and Therapeutic Prospects
Shijia Wang, Xiangbin Zhu, Na Li, Kunfu Ouyang, Zhiyong Liao · 2026 · Cells
Integrative Omics Analysis Reveals a CD206 + Macrophage/Dendritic Cell–CD155–TIGIT + Regulatory T Cell Axis as a Protective Immune Checkpoint Pathway in Atherosclerosis Progression
Ying Shao, Fatma Saaoud, M. Issa, Keman Xu, Yifan Lu, Shih‐Yu Hung, Juanjuan Liu, Bo Yuan, Juncheng Wei, Sheng Wu et al. · 2026 · Barrier Immunity
Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Pathway in High-Risk Lymphocytic Acute Myocarditis
Enrico Ammirati, Gallone Guglielmo, Giacomo Veronese, ERIC D. ADLER, Mikko Ilari Mäyränpää, Emanuela Bonoldi, Duccio Petrella, Paul J. Kim, Michela Brambatti, Matteo Pio Vaira et al. · 2026 · JACC Advances
Immune checkpoint inhibitor-related myocarditis, myositis, and myasthenia gravis overlap syndrome: a single-center case series and systematic review
Jorge Luis Soriano-Lorenzo, Miguel Martínez-Rubiño, Miren Vicente, Martina Pellicer Pérez, Arantxa Bergua de Roque, Sofia Tanco Mulero, Claudia Miquel Bosh, Ana Chen-Ye, Deborah Martin Ruiz, Ines Torras-Vigo et al. · 2026 · Supportive Care in Cancer
Management and Surveillance of Immune Checkpoint Inhibitor Myocarditis: Managing the Aftermath
Tyler T. Morad, Mohammad Keykhaei, Devon A. Terraciano, Pratyaksh K. Srivastava, Eric H. Yang, Ashley F. Stein-Merlob · 2026 · JACC CardioOncology